{"transactions":[{"id":931159,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T12:00:04.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date is January 1, 2026.  The stock option vests in 48 substantially equal monthly installments.  Accordingly, 1/48th of this stock option vests on February 1, 2026, and monthly thereafter."}],"balance_after":600000,"derivative":{"exercise_price":1.26,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001193125-26-021655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000119312526021655/ownership.xml","form_type":"4"}},{"id":1296343,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2025-01-23T21:05:09.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 48 substantially equal monthly installments beginning on February 1, 2025."}],"balance_after":295000,"derivative":{"exercise_price":2.57,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0000950170-25-008318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017025008318/ownership.xml","form_type":"4"}},{"id":1427604,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":162343,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"premium end date\" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a \"qualifying termination\" (as defined below). The \"premium end date\" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A \"qualifying termination\" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024."}],"balance_after":162343,"derivative":{"exercise_price":3.56,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":162343},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427603,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":257207,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"premium end date\" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a \"qualifying termination\" (as defined below). The \"premium end date\" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A \"qualifying termination\" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024."}],"balance_after":257207,"derivative":{"exercise_price":3.56,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":257207},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427602,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":471282,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"premium end date\" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a \"qualifying termination\" (as defined below). The \"premium end date\" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A \"qualifying termination\" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023."}],"balance_after":471282,"derivative":{"exercise_price":3.56,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":471282},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427601,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":256410,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the option is $3.56 per share, representing the fair market value per share of the common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the \"premium end date\" (as defined below), the repriced option is exercised or the reporting person's employment is terminated for any reason other than a \"qualifying termination\" (as defined below). The \"premium end date\" means the earliest of: (i) August 19, 2026, (ii) the date immediately prior to the closing of a change in control, or (iii) the date of the employee's qualifying termination. A \"qualifying termination\" means (a) the involuntary termination of the employee's employment by the Company due to a reduction in force (and other than for cause), or (b) the employee's termination due to death or disability."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021."}],"balance_after":256410,"derivative":{"exercise_price":3.56,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":256410},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427600,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":162343,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":162343},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427599,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":257207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in 48 substantially equal monthly installments beginning on March 15, 2024."}],"balance_after":0,"derivative":{"exercise_price":8.19,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":257207},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427598,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":471282,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 48 substantially equal monthly installments beginning on July 13, 2023."}],"balance_after":0,"derivative":{"exercise_price":4.1,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":471282},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1427597,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-08-20T23:10:39.000Z","date":"2024-08-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":256410,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 19, 2024, the Issuer repriced the option. Except as described further in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 48 substantially equal monthly installments beginning on July 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":4.1,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":256410},"source":{"system":"sec-edgar","filing":"0000950170-24-099306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024099306/ownership.xml","form_type":"4"}},{"id":1557545,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2024-03-29T20:30:27.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":162343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024."}],"balance_after":162343,"derivative":{"exercise_price":16,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":162343},"source":{"system":"sec-edgar","filing":"0000950170-24-038696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000095017024038696/ownership.xml","form_type":"4"}},{"id":4066203,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:31:39.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-009145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919118009145/doc4.xml","form_type":"4"}},{"id":4066202,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:31:39.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6.58,"expiration_date":"2025-01-07","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-18-009145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919118009145/doc4.xml","form_type":"4"}},{"id":4066201,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:31:39.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2023-12-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-009145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919118009145/doc4.xml","form_type":"4"}},{"id":4066200,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:31:39.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":1.02,"expiration_date":"2023-09-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-009145","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919118009145/doc4.xml","form_type":"4"}},{"id":4066199,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-02-12T20:31:39.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":165748,"price":27,"value":4475196.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the acquisition of the Issuer by Roche Holdings, Inc. (\"Parent\") on February 8, 2018, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Abingdon Acquisition Corp. (\"Merger Sub\") dated December 21, 2017, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the \"Shares\") for a purchase price of $27.00 per Share (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-009145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919118009145/doc4.xml","form_type":"4"}},{"id":4120181,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-12-29T02:35:36.000Z","date":"2017-12-26","kind":"tax_withholding","acquired":false,"shares":18552,"price":26.7,"value":495338.4,"ownership":{"direct":true},"balance_after":165748,"source":{"system":"sec-edgar","filing":"0000899243-17-029702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000089924317029702/doc4.xml","form_type":"4"}},{"id":4122467,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-12-23T02:45:37.000Z","date":"2017-12-22","kind":"grant","acquired":true,"shares":37167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest as to 25% of the shares underlying each award on each anniversary of the Grant Date, subject to the Reporting Person's continues service with the Company through the vesting date."}],"balance_after":184300,"source":{"system":"sec-edgar","filing":"0001209191-17-067160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117067160/doc4.xml","form_type":"4"}},{"id":4331743,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of May 3, 2017 and prior to this transaction, 44,791 shares of common stock subject to the option vested. Approximately 1,041 shares of common stock subject to the option vest on the ninth day of each month until September 9, 2017."}],"balance_after":40000,"derivative":{"exercise_price":1.02,"expiration_date":"2023-09-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4331742,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":false,"shares":1389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2023-02-14","underlying":"Common Stock","underlying_shares":1389},"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4331741,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":false,"shares":2083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.57,"expiration_date":"2022-12-10","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4331740,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":true,"shares":10000,"price":1.02,"value":10200.0,"ownership":{"direct":true},"balance_after":147133,"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4331739,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":true,"shares":1389,"price":0.6,"value":833.4,"ownership":{"direct":true},"balance_after":137133,"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4331738,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-05-05T18:25:50.000Z","date":"2017-05-03","kind":"exercise","acquired":true,"shares":2083,"price":0.57,"value":1187.31,"ownership":{"direct":true},"balance_after":135744,"source":{"system":"sec-edgar","filing":"0001209191-17-030260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117030260/doc4.xml","form_type":"4"}},{"id":4496485,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":68798,"kind":"person","name":"Hornby Zachary","position":1,"cik":"0001602227","reported_name":"Hornby Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T23:46:59.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests.  25% of the shares subject to the option vest on January 5, 2018, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":60000,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-002763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602227/000120919117002763/doc4.xml","form_type":"4"}}]}